Shield Therapeutics plc Net Asset Momentum
Shield Therapeutics plc net asset momentum. Shield Therapeutics plc (STX) recorded a net asset momentum of -104.7% as of December 2024, with net assets of GBX-1.05 Million GBX. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore reinvestment intensity of Shield Therapeutics plc to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Shield Therapeutics plc (2013–2024)
Net asset momentum of Shield Therapeutics plc from 2013 to 2024. This chart tracks Shield Therapeutics plc's year-over-year net asset growth across 12 annual reporting periods from 2013 to 2024. The most recent momentum reading is -104.7%, with net assets of GBX-1.05 Million GBX as of December 2024. See shareholders equity of Shield Therapeutics plc for net asset value and shareholders' equity analysis.
Shield Therapeutics plc Net Asset Momentum by Year (2013–2024)
Shield Therapeutics plc net asset momentum by year from 2013 to 2024. The table below shows the complete annual net asset history for Shield Therapeutics plc from 2013 to 2024, covering 12 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see STX company net worth.
| Year | Net Assets (GBX) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | GBX-1.05 Million | GBX45.90 Million | GBX46.95 Million | ▼ -104.7% |
| 2023 | GBX22.31 Million | GBX48.80 Million | GBX26.49 Million | ▲ +311.1% |
| 2022 | GBX5.43 Million | GBX22.07 Million | GBX16.65 Million | ▼ -86.8% |
| 2021 | GBX41.03 Million | GBX44.41 Million | GBX3.38 Million | ▲ +35.5% |
| 2020 | GBX30.28 Million | GBX32.53 Million | GBX2.25 Million | ▼ -5.8% |
| 2019 | GBX32.15 Million | GBX36.32 Million | GBX4.17 Million | ▼ -20.5% |
| 2018 | GBX40.43 Million | GBX43.38 Million | GBX2.95 Million | ▼ -1.9% |
| 2017 | GBX41.21 Million | GBX44.97 Million | GBX3.76 Million | ▼ -14.9% |
| 2016 | GBX48.40 Million | GBX52.38 Million | GBX3.99 Million | ▲ +359.6% |
| 2015 | GBX-18.64 Million | GBX2.86 Million | GBX21.50 Million | ▼ -2.0% |
| 2014 | GBX-18.28 Million | GBX1.00 Million | GBX19.29 Million | ▼ -204.5% |
| 2013 | GBX-6.00 Million | GBX2.04 Million | GBX8.05 Million | — |